ArticleThe Journal of infectious diseases2020

Modeling-Based Response-Guided Glecaprevir-Pibrentasvir Therapy for Chronic Hepatitis C to Identify Patients for Ultrashort Treatment Duration.

Swikriti Dasgupta et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.